Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer
Authors not listed
CHU de Reims · 2014
Abstract
The aim of the study is to evaluate frailty in patients aged ≥ 65 years with cancer. The elderly population is very heterogeneous, it is necessary to evaluate these elderly patients before treatment to assess the risk-benefit balance. To date, this assessment relies on subjective clinical methods often not optimal, and slow to implement. An innovative method of evaluation could be the determination of elastin peptides. Indeed, the rate of these peptides, which are linked to serious conditions associated with age, rising inexorably with age and dose could help determine more objectively the type of treatment to offer older patients.
Expected results : This study will allow better identification of the group of frail elderly through more relevant biological marker that clinical assessment, often subjective and not available within a period compatible with the treatment of newly diagnosed cancer. This biological assessment will also enable optimal management of elderly patients in particular by allowing the geriatrician better efficiency.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Anonymous. (2014). Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer. <em>CHU de Reims</em>. https://clinicaltrials.gov/study/NCT02807129
Vancouver
Anonymous. Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer. CHU de Reims. 2014.
BibTeX
@misc{anon2014Fragme,
title = {Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer},
author = {Anonymous},
journal = {CHU de Reims},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
St Joseph University, Beirut, Lebanon 2019
Open access · US-GOV
The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment: A Prospective Randomized Controlled Trial
University Hospital of Ferrara 2024
Open access · US-GOV
Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction
University of Milano Bicocca 2020
Open access · US-GOV
Relationship Between Frailty and Clinical Outcomes in Elderly Patients With COVID-19
JAMA Neurology 2024
Preprint · CC-BY
Frailty Trajectories Preceding Dementia in the US and UK
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2024
Open access · US-GOV
Hypofractionated Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Elderly Patients: A Prospective Phase II Clinical Study
University Hospital, Strasbourg, France 2024
Open access · US-GOV